Claya vs NovoCare Pharmacy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Claya
Best for compounded GLP-1 in injectable and oral-tablet forms with named cliniciansStarting at $179/mo
NovoCare Pharmacy
Best for branded Wegovy at the lowest manufacturer-direct self-pay priceStarting at $199/mo
Side-by-Side Comparison
| Feature | Claya | NovoCare Pharmacy |
|---|---|---|
| Overall Score | 7.0/10 | ✓8.7/10 |
| Starting Price | ✓$179/mo | $199/mo |
| Editorial Rating | 3.5 ★ /5 | ✓4.4 ★ /5 |
| Features | ✓7 features | 5 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Claya
Pros
- ✓Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- ✓Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- ✓Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- ✓Weight-loss money-back guarantee published on the homepage
- ✓Free expedited shipping included in the monthly price
Cons
- ✗States-served list not disclosed — you must check at checkout
- ✗LegitScript certification status not displayed
- ✗Corporate legal entity not disclosed on the site or privacy policy
- ✗Oral compounded tablets have weaker efficacy data than injectable semaglutide
- ✗Intro pricing is higher at refill ($299), erasing the first-month advantage
NovoCare Pharmacy
Pros
- ✓First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
- ✓$199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
- ✓$349/mo standard self-pay is well below the ~$1,300/mo retail list price
- ✓Ships to all 50 states with no telehealth-platform middleman fees
- ✓Cold-chain logistics handled directly by Novo Nordisk
- ✓Insurance-billing path available via the NovoCare savings program
Cons
- ✗Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
- ✗Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
- ✗$199 intro price is limited to 0.25/0.5 mg and ends 6/30/2026; maintenance doses cost $349/mo
- ✗No clinical support included — your own prescriber handles titration and side effects
- ✗Manufacturer-set pricing can change at any time
Our Verdict
NovoCare Pharmacy edges out Claya with a higher overall score of 8.7/10 and is particularly strong for branded Wegovy at the lowest manufacturer-direct self-pay price. Claya remains a solid alternative, especially if you're looking for compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Claya and NovoCare Pharmacy head-to-heads in the same category.
- Claya vs CoreAge Rx
- Claya vs TrimRx
- Claya vs Amazon One Medical
- NovoCare Pharmacy vs Vytora Health
- NovoCare Pharmacy vs Enhance MD
- NovoCare Pharmacy vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.